Pharmacoeconomics comes of age?
- PMID: 18563057
- DOI: 10.1038/clpt.2008.122
Pharmacoeconomics comes of age?
Abstract
Health services throughout the world face increasing demands on their limited resources, and decisions on the best use of these need to be informed by an examination of the costs and benefits of various options. Health economics provides a structure for this, whereas pharmacoeconomics adopts and applies the principles and methodologies of health economics to the field of pharmaceuticals and pharmaceutical policy.
Similar articles
-
Pharmacoeconomics: the new dismal science.Adm Policy Ment Health. 2004 May;31(5):425-7. doi: 10.1023/b:apih.0000034419.84114.fb. Adm Policy Ment Health. 2004. PMID: 15379388 No abstract available.
-
Will lower drug prices jeopardize drug research? A policy fact sheet.Am J Bioeth. 2004 Winter;4(1):W1-4. doi: 10.1162/152651604773067488. Am J Bioeth. 2004. PMID: 15035915 No abstract available.
-
Early benefit assessment for pharmaceuticals in Germany: lessons for policymakers.Issue Brief (Commonw Fund). 2013 Oct;29:1-9. Issue Brief (Commonw Fund). 2013. PMID: 24171232
-
[Use of pharmacoeconomics analyses to health protection].Wiad Lek. 2002;55 Suppl 1:76-9. Wiad Lek. 2002. PMID: 15002222 Review. Polish.
-
Pharmacoeconomics.Natl Med J India. 2004 Mar-Apr;17(2):80-3. Natl Med J India. 2004. PMID: 15141600 Review.
Cited by
-
Drugs, money and society (Part II).Br J Clin Pharmacol. 2010 Sep;70(3):342-5. doi: 10.1111/j.1365-2125.2009.03569.x. Br J Clin Pharmacol. 2010. PMID: 20716232 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources